Copyright
©The Author(s) 2021.
World J Clin Cases. Sep 26, 2021; 9(27): 8061-8070
Published online Sep 26, 2021. doi: 10.12998/wjcc.v9.i27.8061
Published online Sep 26, 2021. doi: 10.12998/wjcc.v9.i27.8061
Table 6 Comparison of the 3-year progression-free survival rate and overall survival rate between the two groups, n (%)
| Group | n | Progression-free survival | Overall survival |
| Test group | 60 | 26 (43.33) | 29 (48.33) |
| Control group | 60 | 16 (26.67) | 20 (33.33) |
| χ2 | 3.663 | 2.794 | |
| P value | 0.056 | 0.095 |
- Citation: Zhao FJ, Su Q, Zhang W, Yang WC, Zhao L, Gao LY. Endu combined with concurrent chemotherapy and radiotherapy for stage IIB-IVA cervical squamous cell carcinoma patients. World J Clin Cases 2021; 9(27): 8061-8070
- URL: https://www.wjgnet.com/2307-8960/full/v9/i27/8061.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i27.8061